How is Romidepsin dosed?
The recommended dose of Romidepsin for the treatment of CTCL in patients who have received at least 1 previous treatment is 14 mg/m2 as an intravenous infusion over 4 hours. The dosing should be repeated every 7 days for a total of 8 weeks (4 cycles). Dosing and frequency may vary based on individual patient factors and medical conditions. Follow your doctor's instructions and consult with a healthcare professional for proper dosing.
What is the dosage form of Romidepsin?
Romidepsin is available in the following dosage forms for intravenous route: Solution, Powder for Solution
How is Romidepsin administered?
Romidepsin is administered under the direct supervision of a doctor. It is available in the form of a solution or powder for solution. The appropriate dosage and frequency of administration depend on the individual patient's condition and treatment plan. Follow the doctor's instructions carefully when administering this medication.
What are common precautions when taking Romidepsin?
Common precautions when taking Romidepsin include:
- Allergies: Inform your doctor if you have had any unusual or allergic reactions to this medicine or any other medicines.
- Pediatric Use: Safety and efficacy have not been established in pediatric patients.
- Geriatric Use: Elderly patients may be more sensitive to the effects of this medicine than younger adults.
- Breastfeeding: Consult with your doctor before taking this medication while breastfeeding.
- Drug Interactions: Consult your doctor before using Romidepsin with other medicines.